8-K: SRx Health Changes Auditor Amid Financial Control Issues

SRx Health Solutions, Inc. has appointed Davidson and Company LLP as its new independent auditor, replacing CBIZ CPAs P.C., following a series of internal control weaknesses and a revenue recognition error.

Summary

• SRx Health Solutions, Inc. dismissed CBIZ CPAs P.C. as its independent registered public accounting firm on September 15, 2025.
• Davidson and Company LLP was engaged as the new independent auditor for the fiscal year ending September 30, 2025.
• The previous auditor for Better Choice Company, Inc. (Marcum LLP) included a "going concern" explanatory paragraph in its December 31, 2024 report and noted material weaknesses in revenue recognition and IT general controls.
• The previous auditor for SRx Canada (MNP LLP) included "going concern" explanatory paragraphs in its September 30, 2023 and 2024 reports and identified multiple material weaknesses, including management override of controls and insufficient accounting analyses.
• An error was identified in revenue recognition, overstating revenue by approximately USD 1.8 million in the fiscal year ended September 30, 2024, which the company will revise in its upcoming Form 10-Q.
• The company expects an additional material weakness related to revenue recognition.
• SRx Canada's CCAA creditor protection proceedings are ongoing, with the majority of its assets sold through court-approved transactions expected to close in the next several weeks.

Sentiment

Score: 2

Explanation: The filing reveals significant negative events including auditor dismissal, persistent 'going concern' issues, numerous material weaknesses in internal controls, a material revenue overstatement, and the ongoing creditor protection and asset sales of a key subsidiary. These factors collectively point to severe financial and operational distress.

Positives

• Engagement of a new independent auditor, Davidson and Company LLP, may signal a fresh start for financial oversight.
• The company is actively addressing identified accounting errors and internal control weaknesses.

Negatives

• Dismissal of the previous auditor, CBIZ, shortly after the merger.
• Persistent "going concern" issues noted by previous auditors for both Better Choice Company, Inc. and SRx Canada.
• Multiple material weaknesses in internal control over financial reporting identified for both predecessor companies, including revenue recognition, IT controls, management override, and valuation support.
• Identification of a USD 1.8 million revenue overstatement for fiscal year 2024, requiring revision of financial statements.
• Expectation of an additional material weakness related to revenue recognition.
• SRx Canada is undergoing creditor protection (CCAA proceedings) and has sold off the majority of its assets, indicating significant operational distress.

Risks

• Ability to continue as a going concern due to conditions described by previous auditors.
• Ineffective internal controls over financial reporting, particularly concerning revenue recognition, IT general controls, and accounting analyses.
• Risk of further financial misstatements or errors due to identified material weaknesses.
• Operational and financial instability stemming from SRx Canada's ongoing creditor protection and asset sales.
• Reputational risk associated with auditor changes and persistent control deficiencies.

Future Outlook

The company expects to revise its fiscal year 2024 financial statements in its upcoming Form 10-Q for the period ended June 30, 2025, to correct a USD 1.8 million revenue overstatement. An additional material weakness related to revenue recognition is also anticipated. The majority of SRx Canada's assets, sold through CCAA proceedings, are expected to close in the next several weeks.

Management Comments

• Management and the Audit Committee concluded that the USD 1.8 million revenue overstatement error was not material to the company's previously issued audited financial statements.
• The company will revise, rather than restate, the fiscal year 2024 financial statements when presented in its Form 10-Q for the period ended June 30, 2025.
• The company expects an additional material weakness related to revenue recognition.

Industry Context

The healthcare and pharmaceutical industries, particularly those involving prescription fulfillment, are subject to complex revenue recognition standards and stringent internal control requirements. Persistent 'going concern' issues and material weaknesses in financial reporting, especially concerning revenue and IT controls, are significant red flags that can erode investor confidence and indicate fundamental operational challenges, potentially impacting the company's competitive standing within the health solutions sector.

Corporate Governance

Legal Proceedings

• SRx Canada sought and obtained creditor protection under the federal Companies Creditors Arrangement Act (CCAA), with proceedings ongoing in the Ontario Superior Court of Justice (Commercial List).

Stakeholder Impact

• Shareholders: Face significant uncertainty due to "going concern" issues, material weaknesses in financial reporting, a revenue overstatement, and the ongoing creditor protection and asset sales of SRx Canada, which could negatively impact share value.
• Creditors: SRx Canada's CCAA proceedings and asset sales directly impact creditors, as their claims are being managed through a court-supervised process.
• Employees: The sale of SRx Canada's assets could lead to job losses or changes for employees associated with those operations.
• Customers: Potential disruption or changes in service for customers previously served by SRx Canada's divested locations.

Next Steps

• The company will revise its fiscal year 2024 financial statements in its Form 10-Q for the period ended June 30, 2025.
• The majority of SRx Canada's court-approved asset sales are expected to close in the next several weeks.
• The CCAA proceedings for SRx Canada are ongoing.

Key Dates

Recommendation

The filing reveals a deeply troubled company. The dismissal of an auditor shortly after a merger, coupled with persistent 'going concern' warnings from *both* predecessor companies' auditors, indicates severe financial instability. The extensive list of material weaknesses in internal controls, including management override and critical deficiencies in revenue recognition and IT, points to fundamental governance and operational failures. The discovery of a USD 1.8 million revenue overstatement and the expectation of *another* material weakness further erode confidence in financial reporting. Most critically, the ongoing creditor protection and asset liquidation of SRx Canada, a core part of the merged entity, signals a significant impairment of the company's business model and asset base. These factors collectively present an extremely high-risk profile with substantial downside potential, warranting a strong sell recommendation.

Keywords

SRx Health Solutions, Better Choice Company, auditor change, Form 8-K, SEC filing, internal controls, material weakness, revenue recognition, going concern, CBIZ CPAs, Davidson and Company, SRx Canada, CCAA proceedings, creditor protection, financial reporting, corporate governance